Abstract
Selinexor-Driven Regulation of Proinflammatory Cytokines May Lead to Stabilization of Hematologic Parameters and Bone Marrow Function in Patients with Myelofibrosis: Case Study from the Phase 1 Sentry Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have